Steroid Treatment in Multiple Sclerosis

Abstract

Few diseases fluctuate as much as multiple sclerosis. This makes not only treatment but assessment difficult. Nevertheless, evidence from clinical, imaging, and cerebrospinal fluid studies¹support Professor Compston's findings and conclusions that highdose intravenously administered methylprednisolone shortens the course of acute exacerbations and relieves spasticity in chronic cases. Professor Compston states that this represents only a modest advance in the treatment of multiple sclerosis. A little is a lot where there is little else. Reference